Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance

Samankaltaisia teoksia

• Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase and Their Interactions with the M184I Mutation on Defining Patterns of Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Rilpivirine and Etravirine
  Tekijä: Xu, Hong-Tao, et al.
  Julkaistu: (2013)
• Future of nonnucleoside reverse transcriptase inhibitors
  Tekijä: Sluis-Cremer, Nicolas
  Julkaistu: (2018)
• Replicative Fitness Costs of Nonnucleoside Reverse Transcriptase Inhibitor Drug Resistance Mutations on HIV Subtype C
  Tekijä: Armstrong, Kimberly L., et al.
  Julkaistu: (2011)
• Nonnucleoside Reverse Transcriptase Inhibitor Hypersusceptibility and Resistance by Mutation of Residue 181 in HIV-1 Reverse Transcriptase
  Tekijä: Barnard, John P., et al.
  Julkaistu: (2019)
• Factors Associated with Virological Response to Etravirine in Nonnucleoside Reverse Transcriptase Inhibitor-Experienced HIV-1-Infected Patients
  Tekijä: Marcelin, Anne-Genevieve, et al.
  Julkaistu: (2010)